Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

US Patent 7169898 · Granted Jan 30, 2007

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant CD83 promoter and use thereof2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012
Soluble CD83 proteins and use thereof for the treatment and prevention of a dise2012